PATENTS

11. Method for Nucleic Acids Cleavage
Mikutis S, Tzelepis K; Bernardes GJL; EP20386040.8 (2020).


10. Treatment of Immunosuppressive Cancer
Labão–Almeida C; Bernardes GJL; GB Patent Application No: 2004514.2 (2020).


9. Inhibitors of RNA-binding proteins as anti-cancer drugs
Hüttelmaier S;Bertoldo JB; Müller S; Bernardes GJL; EP Patent Application No: 20159945.3 (2020).


8. Compounds
Seixas JD; Bernardes GJL; GB Patent Application No: 1908171.0 (2019).


7. Treatment of obesity-related conditions
Domingos A; Bernardes GJL; WO 2019/076675 (2018).


6. TRPV2 Antagonists
Rodrigues T; Baker C; Conde J; Bernardes GJL; WO 2019/054891 (2018).


5. 5-Lipoxygenase Antagonists
Rodrigues T; Bernardes GJL; WO 2019/050422 (2018).


4. Methods for protein stapling
Martinez-Saez N; Sun S; Boutureira O; Corzana F; Bernardes GJL; GB Patent Application No: GB1704922.2 (2017).


3. Ruthenium carbon monoxide releasing compounds and uses thereof for treatment of inflammatory conditions
Pamplona A; Bernardes GJL; Mota MM; Romão CC; PCT/US2012047661 (2013).


2. Chemical modification of proteins by selective conversion of cysteine and alkyl cysteines to dehydroalanine on proteins surfaces as switchable access to functionalized proteins
Bernardes GJL; Chalker JM; Davis BG; PCT Int. Appl. (2009), WO 2009103941 A1 20090827.


1. Process of forming sulfide bridges using glycoside amino acids”
Davis BG; Bernardes GJL; PCT Int. Appl. (2009), WO 2009098437 A2 20090813.